These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7862157)

  • 1. Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development.
    Satake M; Nomura S; Yamaguchi-Iwai Y; Takahama Y; Hashimoto Y; Niki M; Kitamura Y; Ito Y
    Mol Cell Biol; 1995 Mar; 15(3):1662-70. PubMed ID: 7862157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.
    Bae SC; Ogawa E; Maruyama M; Oka H; Satake M; Shigesada K; Jenkins NA; Gilbert DJ; Copeland NG; Ito Y
    Mol Cell Biol; 1994 May; 14(5):3242-52. PubMed ID: 8164679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain.
    Bae SC; Takahashi E; Zhang YW; Ogawa E; Shigesada K; Namba Y; Satake M; Ito Y
    Gene; 1995 Jul; 159(2):245-8. PubMed ID: 7622058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2.
    Takahashi A; Satake M; Yamaguchi-Iwai Y; Bae SC; Lu J; Maruyama M; Zhang YW; Oka H; Arai N; Arai K
    Blood; 1995 Jul; 86(2):607-16. PubMed ID: 7605990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1.
    Bae SC; Yamaguchi-Iwai Y; Ogawa E; Maruyama M; Inuzuka M; Kagoshima H; Shigesada K; Satake M; Ito Y
    Oncogene; 1993 Mar; 8(3):809-14. PubMed ID: 8437866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
    Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
    Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cells.
    Britos-Bray M; Sacchi N; Friedman AD
    Leukemia; 1996 Jun; 10(6):984-90. PubMed ID: 8667656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
    Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.
    Ogawa E; Inuzuka M; Maruyama M; Satake M; Naito-Fujimoto M; Ito Y; Shigesada K
    Virology; 1993 May; 194(1):314-31. PubMed ID: 8386878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor.
    Erickson PF; Robinson M; Owens G; Drabkin HA
    Cancer Res; 1994 Apr; 54(7):1782-6. PubMed ID: 8137293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
    Zent C; Rowley JD; Nucifora G
    Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells.
    Nuchprayoon I; Meyers S; Scott LM; Suzow J; Hiebert S; Friedman AD
    Mol Cell Biol; 1994 Aug; 14(8):5558-68. PubMed ID: 8035830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.
    Zent CS; Mathieu C; Claxton DF; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1044-8. PubMed ID: 8577711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AML1 fusion transcripts in t(3;21) positive leukemia: evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts.
    Sacchi N; Nisson PE; Watkins PC; Faustinella F; Wijsman J; Hagemeijer A
    Genes Chromosomes Cancer; 1994 Dec; 11(4):226-36. PubMed ID: 7533526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene.
    Ogawa E; Maruyama M; Kagoshima H; Inuzuka M; Lu J; Satake M; Shigesada K; Ito Y
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6859-63. PubMed ID: 8341710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF.
    Lu J; Maruyama M; Satake M; Bae SC; Ogawa E; Kagoshima H; Shigesada K; Ito Y
    Mol Cell Biol; 1995 Mar; 15(3):1651-61. PubMed ID: 7862156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
    Nucifora G; Rowley JD
    Leuk Lymphoma; 1994 Aug; 14(5-6):353-62. PubMed ID: 7812194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
    Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
    Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of MTG8 in leukemogenesis.
    Kozu T; Komori A; Sueoka E; Fujiki H; Kaneko Y; Matsui T; Uehara T; Seino Y; Ishii M
    Leukemia; 1997 Apr; 11 Suppl 3():297-8. PubMed ID: 9209371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.